Background: The purpose of this study was to evaluate the occurrence of lymphatic complications following pelvic lymphadenectomy (PLA) in patients with cervical cancer. Methods: A retrospective study of 169 cervical cancer patients was conducted. Lower extremity lymphedema (LEL) was diagnosed using the International Society of Lymphology guidelines, and pelvic lymphocele (PL) was evaluated using trans-vaginal ultrasonography and computed tomography. Results: The median patient age was 46 years (range: 22-74) and median body mass index was 21.7 kg/m 2 (range: 15.7-37.1). The median number of lymph nodes (LNs) removed was 27 (range:
Introduction
Cervical cancer is one of the most common gynecologic cancers, and lymph node (LN) metastasis has been identified as an important prognostic factor for survival (1, 2) . Radical hysterectomy with pelvic lymphadenectomy (PLA) is a standard treatment in cervical cancer patients (3, 4) . However, PLA has been associated with numerous morbidities, such as massive bleeding, nerve injury, lower extremity lymphedema (LEL) and pelvic lymphocele (PL) (5) . In particular, severe postoperative lymphatic complications (LEL and PL) have been shown to greatly reduce quality of life (6) . Because severe LEL generally presents as a chronic and irreversible disease, patients require long-term care and attention, along with psychological support (7) . Postoperative radiotherapy (8) and removal of the circumflex iliac nodes (CIN) following PLA (5,9-11) are significant predictive factors for LEL. Most cases of PL are asymptomatic and are often detected on routine imaging studies during postoperative follow-up. However, severe PL with infection requires treatment, and this can delay adjuvant cancer therapy.
To the best of our knowledge, there have been few studies describing the incidence of both LEL and PL in a large cohort of cervical cancer patients. The aim of this study was therefore to evaluate the incidence of postoperative lymphatic complications (LEL and PL) in patients with cervical cancer.
Materials and methods
We retrospectively reviewed 169 patients with stage IA2-IIB cervical cancer (according to the International Federation of Gynecology and Obstetrics [FIGO] staging system) who underwent radical or modified radical hysterectomy with PLA at the Department of Obstetrics and Gynecology in Kagoshima University Hospital between April 2007 and August 2017. This study was approved by the institutional ethics committee and informed consent was obtained from all patients. FIGO staging was based on clinical examination, and preoperative results from computed tomography (CT) and magnetic resonance imaging (MRI) scans. Radical or modified radical hysterectomy was performed by laparotomy, laparoscopy or robotic surgery. The retroperitoneum was left open at the end of surgical procedure in all patients.
Adjuvant therapy (irradiation to the whole pelvis or chemotherapy) was administered to patients with tumors that were >4 cm, had a depth of cervical stromal invasion greater than half or had parametrial involvement, and to those who had positive pelvic LN metastases proven by postoperative pathological examination.
Diagnosis of lymphatic complications
Patient information was collected by gynecologic oncologists after every follow-up visit to an outpatient clinic. Patients were excluded from the study if they had another active cancer or any other disease, such as pulmonary or heart disease. LEL was diagnosed using the International Society of Lymphology guidelines (7) .
On the other hand, PL was evaluated by trans-vaginal ultrasonography and CT scan, according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) v4.0. Based on these criteria, Grade 1 (asymptomatic) refers to clinical or diagnostic observations only; intervention is not indicated for this grade. For Grade 2 (symptomatic), medical intervention is indicated and for Grade 3 (severe symptoms) radiologic, endoscopic or elective operative intervention is indicated.
Statistical analysis
Differences in proportions were evaluated by the Chi-square test or Fisher's exact test, as appropriate. Independent prognostic significance was calculated using logistic regression analysis. JMP software (SAS Institute Inc., Cary, NC, USA) was used for statistical analysis. A P value <0.05 was considered statistically significant.
Results

Patient characteristics
Between April 2007 and August 2017, 169 patients with cervical cancer were recruited into this study. The clinicopathological characteristics of patients are shown in Data is given as median (range) or n (%). BMI, body mass index; SCC, squamous cell carcinoma; FIGO, International Federation of Gynecology and Obstetrics; LNs, lymph nodes; CIN, circumflex iliac node; LEL, lower extremity lymphedema; PPL, postoperative pelvic lymphocele.
Lower extremity lymphedema
Of the 169 patients, 28 (16.6%) had LEL. LEL was unilateral in 23 (13.6%) patients (14 and 9 cases on the left and right sides, respectively), and bilateral in 5 (3.0%) patients. LEL occurred at a median time of 6 months post-surgery. Twenty-three (82.1%) patients developed LEL within 12 months, 26 (92.9%) within 24 months and 27 (96.4%) within 36 months. LEL stages 0, I, II and III were present in 141 (83.4%), 13 (7.7%), 10 (5.9%) and 5 (3.0%) patients, respectively. There was no significant relationship between the occurrence of LEL with age, BMI, final pathology, FIGO stage, LN metastasis, adjuvant chemotherapy or adjuvant radiotherapy. However, the number of LNs removed and CIN removal were both correlated with the occurrence of LEL (Table 2 ). In multivariate logistic regression analysis, the number of LNs removed and CIN removal were both independent risk factors for LEL (Table 3) .
Pelvic lymphocele
Of the 169 patients, 32 (18.9%) had PL. PL occurred at a median time of 3 months post-surgery, with 31 (97%) patients developing LEL within 12 months, and 1 (3%) within 36 months. PL was divided into grades as 1, 2 and 3 which were present in 25 (78.1%), 3 (9.4%) and 4 (12.5%) patients, respectively. There was no significant relationship between the occurrence of PL with any clinicopathological characteristics (i.e. age, BMI, final pathology, FIGO stage, the number of LNs removed, CIN removal, LN metastasis, adjuvant chemotherapy and adjuvant radiotherapy) ( Table 2) . Furthermore, there was no significant relationship between LEL and PL (data are not shown). Data is given as n (%). LEL, lower extremity lymphedema; PPL, postoperative pelvic lymphocele; BMI, body mass index; SCC, squamous cell carcinoma; FIGO, International Federation of Gynecology and Obstetrics; LNs, lymph nodes; CIN, circumflex iliac node. 
Discussion
This study investigated the incidence of lymphatic complications, specifically LEL and PL, after PLA in patients with cervical cancer. PLA has been performed conventionally as a standard procedure for diagnosis and treatment in patients with cervical cancer. Because LN metastasis is the most important prognostic factor for survival in these patients, lymphatic complications such as LEL and PL have been recognized as unavoidable occurrences. Identification of risk factors for these complications is crucial, as severe postoperative lymphatic complications can greatly reduce patients' quality of life (6) .
Of the 169 patients enrolled in our study, we identified 28 (16.6%) patients with LEL. Previous studies have reported the incidence of LEL as being between 20.1% and 42% (5, (12) (13) (14) (15) , which is slightly higher than in the present study. Achouri et al. (12) reported that LEL occurred from 1 to 18 months after surgery, and that 80% of patients received a diagnosis within 12 months. Hareyama et al. (5) reported that LEL occurred within 1 year of surgery in 60.3% patients and in 82.1% within 3 years. In our study, 23 (82.1%) patients were diagnosed with LEL within 1 year, and 27 (96.4%) within 3 years. It is a possibility that LEL develops immediately after surgery. On the basis of these results, we suggest that patients be educated on self-management techniques shortly after surgery to prevent the occurrence of LEL.
In our study, the number of LNs removed and CIN removal were significant risk factors for LEL in patients with cervical cancer. Similarly, Hareyama et al. (5) reported that the number of LNs removed was an independent risk factor for LEL. Most previous studies concluded that comprehensive lymphadenectomy is a risk factor for LEL (5, 11, 15) . However, there are also some reports that have found no significance between development of LEL and the number of LNs removed (12, 16) . One reason for this inconsistency may be the large differences in the number of LNs removed between different studies.
In our study, removal of CIN was another significant risk factor for LEL. In agreement with this result, numerous previous reports have also concluded that CIN removal is a major risk factor for LEL (9, 10, 14, 17) . Hareyama et al. reported that fine lymphatic vessels were protected by a preserving CIN and that collateral pathways developed from the preserved CIN along the iliac and large abdominal vessels (17) . We believe that preservation of the CIN is one of the best ways to prevent development of LEL.
Previous reports showed that radiotherapy is a risk factor of LEL. However, Füller et al. (15) reported that radiotherapy had no influence on the incidence of LEL, and Snijders-Keilholz et al. (18) reported that LEL was observed in only 11% of patients who had undergone radiotherapy versus 10% in patients who had not. In our study, LEL was observed in 13% of patients receiving radiotherapy versus 15% in those who had not.
In our study, 32 (18.9%) of 169 patients developed PL. In previous studies, PL occurred in about 10%-25% of patients (12, (19) (20) (21) (22) (23) , which is in keeping with our results. Zikan et al. (23) reported that the incidence of symptomatic lymphocele was 5.8% (46/800), and that the mean time to lymphocele diagnosis was 3.7 months for symptomatic patients. In the present study, 7 of 169 (4.1%) cervical cancer patients had symptomatic PL, and PL occurred at a median time of 3 months post-surgery. Almost all PL cases occurred early after surgery and were asymptomatic; however, patients with symptomatic PL require invasive treatment such as surgery and puncture drainage.
The relationship between PL and clinicopathological features, including the number of LNs removed, is controversial. Some studies have identified the number of LNs removed as a risk factor for PL (21, 23, 24) . For instance, Zikan et al. (23) reported that removal of a total number of >27 LNs was an independent risk factor for symptomatic lymphocele. In contrast, another study found that the number of LNs removed had no significant effect on the risk of symptomatic postoperative lymphocele (12) . In our study, there was no significant relationship between the development of PL and clinical characteristics, including the number of LNs removed. Instead, our results suggest that PL may be correlated with removal of pelvic LNs. Recently, the sentinel lymph node (SLN) concept has become a standard diagnostic procedure for early-stage cervical cancer that enables omission of comprehensive PLA in patients who do not require it (25) . It is our belief that the SLN concept is an effective procedure to prevent lymphatic complications in patients with early cervical cancer.
This study has several limitations. Firstly, the study had a retrospective design. Although a large number of patients were included in this study, it is possible that selection bias may have occurred. Secondly, as LEL was diagnosed by a gynecologist who performed the surgery, there may have been some subjectivity involved in the diagnosis of LEL. Therefore, diagnostic bias of LEL may have occurred in this study. PL, on the other hand, was evaluated using trans-vaginal ultrasonography and CT, both of which are routinely performed in patients with cervical cancer. For this reason, we believe that these diagnostic imaging methods are appropriate for PL diagnosis.
In conclusion, our data demonstrated that the occurrence rate of the lymphatic complications LEL and PL was 16.6% and 18.9%, respectively. We identified CIN removal and the number of LNs removed as significant risk factors for LEL in patients with cervical cancer. However, we did not identify any significant risk factors for PL in this study. To prevent the occurrence of lymphatic complications in patients with cervical cancer, we suggest that comprehensive PLA without CIN dissection, or the SLN concept, should be established as the standard treatment.
